[
  {
    "ts": "2025-09-26T21:50:05+00:00",
    "headline": "Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing",
    "summary": "In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $385.74, indicating a +1.01% shift from the previous trading day.",
    "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-surpasses-market-215005415.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "1cdbf040-4a1f-3e1c-b446-371ddf6e9192",
      "content": {
        "id": "1cdbf040-4a1f-3e1c-b446-371ddf6e9192",
        "contentType": "STORY",
        "title": "Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing",
        "description": "",
        "summary": "In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $385.74, indicating a +1.01% shift from the previous trading day.",
        "pubDate": "2025-09-26T21:50:05Z",
        "displayTime": "2025-09-26T21:50:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/e8e4b0344809eaac6d73c9fd25fd180a",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/77fQuhMZKmmejPyfoX.AMA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e8e4b0344809eaac6d73c9fd25fd180a.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZJQ28vQkERD4a1KYGMCgzA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e8e4b0344809eaac6d73c9fd25fd180a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-surpasses-market-215005415.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-surpasses-market-215005415.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-26T13:30:02+00:00",
    "headline": "Vertex (VRTX) Is Considered a Good Investment by Brokers: Is That True?",
    "summary": "Based on the average brokerage recommendation (ABR), Vertex (VRTX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?",
    "url": "https://finance.yahoo.com/news/vertex-vrtx-considered-good-investment-133002483.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "de4e56a6-f9af-315a-af96-8ebaf75e916c",
      "content": {
        "id": "de4e56a6-f9af-315a-af96-8ebaf75e916c",
        "contentType": "STORY",
        "title": "Vertex (VRTX) Is Considered a Good Investment by Brokers: Is That True?",
        "description": "",
        "summary": "Based on the average brokerage recommendation (ABR), Vertex (VRTX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?",
        "pubDate": "2025-09-26T13:30:02Z",
        "displayTime": "2025-09-26T13:30:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43",
          "originalWidth": 900,
          "originalHeight": 601,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/E8QyPjKtRaOQj91uVCJHQA--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43.cf.webp",
              "width": 900,
              "height": 601,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hjTg63kWHBfUb8JQmmr1kg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vertex-vrtx-considered-good-investment-133002483.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vertex-vrtx-considered-good-investment-133002483.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]